The Fourth International Symposium on Sigma-2 Receptors: Role in Health and Disease
Characterization of Sigma-2 Receptor Ligand-induced Metabolic Stimulation in Human SK-N-SH Neuroblastoma Cells
Wayne D. Bowen, Ph.D.
TMEM-97 Synaptic Localization and Potential Amyloid Beta Interaction in Human Alzheimer’s Disease Cases
Martí Colom Cadena, Ph.D.
University of Edinburgh
The Sigma-2 Receptor/TMEM97, PGRMC1 and LDL Receptor Complex are Responsible for the Cellular Uptake of Aβ42 and its Protein Aggregates
Aladdin A. Riad, Ph.D.
University of Pennsylvania
Quantitative Autoradiography of Sigma Receptors in Postmortem Brains
Jinbin Xu, Ph.D.
Inhibition of miRNA let7i Enhances the Progesterone-induced Neuroprotection
Meharvan Singh, Ph.D.
Loyola University Chicago
Modifying Sigma-2 Receptor Lead-Compounds to Produce Differently Purposed Sigma-2 Targeted Agents
Carmen Abate, Ph.D.
Università degli Studi di Bari
Metabolomic Evidence of Disease Modification in Mild-to-Moderate AD Patients by Sigma-2 Antagonist CT1812
Nicholas J. Izzo, Ph.D.
Clinical Biomarker Evidence for Target Engagement, Reduction of Synaptic Damage and Disease Modification in Alzheimer’s Patients Treated with CT1812
Susan Catalano, Ph.D.
The Grand-scale Biology of PGRMC1: How Eukaryogenesis and the Ediacaran Fauna Illuminate S2R-associated Pathologies like Cancer and Dementia
Michael A. Cahill, Ph.D.
Charles Sturt University